$PRPL
Purple Innovation, Inc. Stock $prpl

$prpl Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000121390023038113 Filed on May 10, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$109.4M	$145.1M	$143.2M
YoY Change	-23.61%	-22.16%	-23.19%
Cost Of Revenue	$66.15M	$94.39M	$91.55M
YoY Change	-27.75%	-22.47%	-7.43%
Gross Profit	$43.22M	$50.73M	$51.63M
YoY Change	-16.28%	-21.57%	-41.0%
Gross Profit Margin	39.52%	34.96%	36.06%
Selling, General & Admin	$61.84M	$58.92M	$67.85M
YoY Change	-8.85%	-37.53%	-1.53%
% of Gross Profit	143.07%	116.14%	131.42%
Research & Development	$3.372M	$2.937M	$2.143M
YoY Change	57.35%	94.63%	26.06%
% of Gross Profit	7.8%	5.79%	4.15%
Depreciation & Amortization	$6.883M	$5.282M	$3.842M
YoY Change	79.15%	69.4%	147.87%
% of Gross Profit	15.92%	10.41%	7.44%
Operating Expenses	$65.21M	$61.85M	$69.99M
YoY Change	-6.83%	-35.44%	-0.86%
Operating Profit	-$21.99M	-$11.12M	-$18.36M
YoY Change	19.74%	-64.27%	-208.66%
Interest Expense	$202.0K	-$967.0K	$2.905M
YoY Change	-93.05%	-124.53%	-66.22%
% of Operating Profit
Other Income/Expense, Net	-$1.346M	$161.4M	$17.00K
YoY Change	-8017.65%	4923.5%	-83.0%
Pretax Income	-$23.34M	$149.3M	-$15.44M
YoY Change	51.11%	-722.69%	-160.32%
Income Tax	$72.00K	$219.5M	-$1.811M
% Of Pretax Income		146.99%
Net Earnings	-$23.30M	-$70.13M	-$13.50M
YoY Change	72.57%	225.53%	-164.91%
Net Earnings / Revenue	-21.3%	-48.32%	-9.43%
Basic Earnings Per Share	-$0.24		-$0.20
Diluted Earnings Per Share	-$0.24	-$0.77	-$201.3K
COMMON SHARES
Basic Shares Outstanding	98.40K shares		67.06K shares
Diluted Shares Outstanding	98.85K shares		67.51K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.53M	$41.75M	$62.70M
YoY Change	-13.03%	-54.42%	-39.6%
Cash & Equivalents	$54.53M	$41.75M	$62.70M
Short-Term Investments
Other Short-Term Assets	$4.598M	$11.94M	$12.75M
YoY Change	-63.92%	-13.28%	40.05%
Inventory	$87.68M	$73.20M	$105.8M
Prepaid Expenses	$7.537M	$7.821M
Receivables	$14.44M	$34.57M	$29.01M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$168.8M	$161.5M	$210.3M
YoY Change	-19.73%	-29.65%	-3.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$134.1M	$239.2M	$195.5M
YoY Change	-31.42%	32.42%	54.19%
Goodwill	$4.897M	$4.897M
YoY Change
Intangibles	$24.30M	$26.22M
YoY Change		98.58%
Long-Term Investments
YoY Change
Other Assets	$2.856M	$1.546M	$221.0M
YoY Change	-98.71%	-99.29%	4.27%
Total Long-Term Assets	$267.7M	$271.9M	$430.7M
YoY Change	-37.83%	-34.16%	23.4%
TOTAL ASSETS
Total Short-Term Assets	$168.8M	$161.5M	$210.3M
Total Long-Term Assets	$267.7M	$271.9M	$430.7M
Total Assets	$436.5M	$433.3M	$640.9M
YoY Change	-31.89%	-32.55%	13.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.84M	$46.44M	$62.88M
YoY Change	-25.52%	-41.77%	4.29%
Accrued Expenses	$37.89M	$38.29M	$39.68M
YoY Change	-4.53%	-19.73%	-1.04%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$365.0K
YoY Change		-100.0%	-81.75%
Total Short-Term Liabilities	$89.60M	$99.42M	$111.4M
YoY Change	-19.55%	-29.99%	-2.9%
LONG-TERM LIABILITIES
Long-Term Debt		$21.55M	$37.35M
YoY Change		-77.1%	-8.67%
Other Long-Term Liabilities	$17.75M	$133.5M	$265.9M
YoY Change	-93.32%	-48.62%	4.82%
Total Long-Term Liabilities	$17.75M	$155.0M	$303.3M
YoY Change	-94.15%	-56.2%	2.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$89.60M	$99.42M	$111.4M
Total Long-Term Liabilities	$17.75M	$155.0M	$303.3M
Total Liabilities	$222.7M	$255.4M	$415.4M
YoY Change	-46.41%	-48.59%	1.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$374.8M	-$351.5M
YoY Change		34.26%
Common Stock	$11.00K	$9.000K
YoY Change		28.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$213.0M	$178.0M	$225.5M
YoY Change
Total Liabilities & Shareholders Equity	$436.5M	$433.3M	$640.9M
YoY Change	-31.89%	-32.55%	13.08%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$23.30M	-$70.13M	-$13.50M
YoY Change	72.57%	225.53%	-164.91%
Depreciation, Depletion And Amortization	$6.883M	$5.282M	$3.842M
YoY Change	79.15%	69.4%	147.87%
Cash From Operating Activities	-$13.50M	$1.701M	-$44.28M
YoY Change	-69.51%	-105.48%	371.58%
INVESTING ACTIVITIES
Capital Expenditures	$2.943M	$4.102M	-$13.08M
YoY Change	-122.5%	-126.36%	5.89%
Acquisitions
YoY Change
Other Investing Activities		$12.00K
YoY Change
Cash From Investing Activities	-$3.098M	-$4.090M	-$13.08M
YoY Change	-76.31%	-73.72%	5.89%
FINANCING ACTIVITIES
Cash Dividend Paid	$100.0K
YoY Change
Common Stock Issuance & Retirement, Net		$5.344M	$93.06M
YoY Change		1321.28%	46430.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$29.38M	-15.00M	28.44M
YoY Change	3.29%	-127.47%	989.69%
NET CHANGE
Cash From Operating Activities	-$13.50M	1.701M	-44.28M
Cash From Investing Activities	-$3.098M	-4.090M	-13.08M
Cash From Financing Activities	$29.38M	-15.00M	28.44M
Net Change In Cash	$12.78M	-17.39M	-28.92M
YoY Change	-144.18%	-317.36%	51.17%
FREE CASH FLOW
Cash From Operating Activities	-$13.50M	$1.701M	-$44.28M
Capital Expenditures	$2.943M	$4.102M	-$13.08M
Free Cash Flow	-$16.45M	-$2.401M	-$31.20M
YoY Change	-47.29%	-84.48%	-1154.16%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	prpl	Common Stock Value2 CommonStockValue2		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37523
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-4078206
CY2023Q1	prpl	Tax Distribution Payable TaxDistributionPayable		usd
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4100 NORTH CHAPEL RIDGE ROAD
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	SUITE 200
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	LEHI
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
CY2023Q1	dei	City Area Code CityAreaCode	(801)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	756-2600
CY2023Q1	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	PRPL
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54530000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41754000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14442000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	34566000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	87681000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	73197000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7537000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7821000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4598000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4117000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	168788000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	161455000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134094000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136673000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	101593000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	102541000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4897000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4897000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24304000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26221000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2856000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1546000	usd
CY2023Q1	us-gaap	Assets Assets	436532000	usd
CY2022Q4	us-gaap	Assets Assets	433333000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	46835000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	46441000	usd
CY2023Q1	prpl	Accrued Sales Returns Current AccruedSalesReturnsCurrent	4118000	usd
CY2022Q4	prpl	Accrued Sales Returns Current AccruedSalesReturnsCurrent	5107000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9666000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6691000	usd
CY2023Q1	us-gaap	Customer Advances Current CustomerAdvancesCurrent	2853000	usd
CY2022Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	4452000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1377000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2978000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2982000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	9804000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14129000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13708000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7639000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8130000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	89599000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	97311000	usd
CY2022Q4	prpl	Debt Debt	23657000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115306000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115599000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17752000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17876000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	222657000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	254443000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	9000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	587753000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	529466000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-374814000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-351514000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	212950000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	177961000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	925000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	929000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	213875000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	178890000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	436532000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	433333000	usd
CY2023Q1	us-gaap	Revenues Revenues	109372000	usd
CY2022Q1	us-gaap	Revenues Revenues	143179000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	66149000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	91553000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	43223000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	51626000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38173000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	49959000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23667000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17888000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3372000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2143000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	65212000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	69990000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-21989000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-18364000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	202000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1023000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	73000	usd
CY2022Q1	us-gaap	Other Income OtherIncome	17000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1217000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3928000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1346000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2922000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-23335000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-15442000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1811000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23407000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-13631000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-107000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-129000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-23300000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-13502000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98404	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67058	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	98852	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	67506	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	178890000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23407000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1192000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	57200000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	213875000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	146541000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-13631000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	542000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	166000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	92895000	usd
CY2022Q1	prpl	Stock Issued During Period Tax Distribution StockIssuedDuringPeriodTaxDistribution	-228000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	226285000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-23407000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-13631000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6883000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3842000	usd
CY2023Q1	prpl	Non Cash Interest NonCashInterest	270000	usd
CY2022Q1	prpl	Non Cash Interest NonCashInterest	148000	usd
CY2022Q1	prpl	Fair Value Warrant Liabilities FairValueWarrantLiabilities	-3928000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1217000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1192000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	542000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1912000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20124000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3576000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-14484000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7136000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-903000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1021000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1076000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	418000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1223000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-15900000	usd
CY2023Q1	prpl	Increase In Accrued Sales Returns IncreaseInAccruedSalesReturns	-989000	usd
CY2022Q1	prpl	Increase In Accrued Sales Returns IncreaseInAccruedSalesReturns	-1970000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2889000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2757000	usd
CY2023Q1	prpl	Increase Or Decrease In Customer Advances IncreaseOrDecreaseInCustomerAdvances	-1599000	usd
CY2022Q1	prpl	Increase Or Decrease In Customer Advances IncreaseOrDecreaseInCustomerAdvances	-5993000	usd
CY2023Q1	prpl	Accrued Rebates And Allowances AccruedRebatesAndAllowances	-6822000	usd
CY2022Q1	prpl	Accrued Rebates And Allowances AccruedRebatesAndAllowances	-3160000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1979000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4197000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13503000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44281000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2943000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12631000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	155000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	447000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3098000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13078000	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	24656000	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	2531000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	55000000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2898000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1242000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	60300000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	98210000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3100000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5315000	usd
CY2023Q1	prpl	Tax Receivable Agreement Liabilities TaxReceivableAgreementLiabilities	269000	usd
CY2022Q1	prpl	Tax Receivable Agreement Liabilities TaxReceivableAgreementLiabilities	5847000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	166000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29377000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28441000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12776000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28918000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41754000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	91616000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54530000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62698000	usd
CY2023Q1	prpl	Cash Paid During The Period For Interest Net Of Amounts Capitalized CashPaidDuringThePeriodForInterestNetOfAmountsCapitalized	39000	usd
CY2022Q1	prpl	Cash Paid During The Period For Interest Net Of Amounts Capitalized CashPaidDuringThePeriodForInterestNetOfAmountsCapitalized	-863000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	43000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	44000	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	3397000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	4730000	usd
CY2022Q1	prpl	Tax Distribution Payable TaxDistributionPayable	228000	usd
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	1	pure
CY2023Q1	prpl	Common Units Percentage CommonUnitsPercentage	0.996	pure
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35756000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires the Company to establish accounting policies and to make estimates and judgments that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The Company regularly makes significant estimates and assumptions including, but not limited to, estimates that affect revenue recognition, accounts receivable and allowance for credit losses, valuation of inventories, sales returns, warranty returns, fair value of assets acquired and liabilities assumed in a business combination, warrant liabilities, stock based compensation, the recognition and measurement of loss contingencies, estimates of current and deferred income taxes, deferred income tax valuation allowances, and amounts associated with the Company’s tax receivable agreement with InnoHold, LLC (“InnoHold”). Predicting future events is inherently an imprecise activity and, as such, requires the use of judgment. Actual results could differ materially from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	prpl	Underwritten Offerings Of Class A Common Stock UnderwrittenOfferingsOfClassACommonStock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>3. Underwritten Offering of Class A Common Stock</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, the Company completed an underwritten offering of 13.4 million shares of Class A common stock at a price of $4.50 per share. The underwriters did not exercise their over-allotment option. The aggregate net proceeds received by the Company from the offering, after deducting offering fees and expenses of $3.1 million, totaled $57.2 million.</span></p>
CY2023Q1	prpl	Offering Fees And Expenses offeringFeesAndExpenses	3100000	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	57200000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	28300000	usd
	prpl	Fair Value Of Class A Common Stock Issued At Closing FairValueOfClassACommonStockIssuedAtClosing	23069000	usd
	prpl	Fair Value Of Class A Common Stock Held In Escrow FairValueOfClassACommonStockHeldInEscrow	1467000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1471000	usd
	prpl	Fair Value Of Effective Settlement Of Preexisting Relationships FairValueOfEffectiveSettlementOfPreexistingRelationships	1672000	usd
	prpl	Transaction Expenses Paid On Behalf Of Intellibed TransactionExpensesPaidOnBehalfOfIntellibed	546000	usd
	prpl	Due To Seller DueToSeller	75000	usd
	prpl	Total Purchase Consideration TotalPurchaseConsideration	28300000	usd
CY2023Q1	prpl	Fair Value Of Common Stock Issued Description FairValueOfCommonStockIssuedDescription	The fair value of common stock issued at closing consisted of approximately 8.1 million shares of Class A common stock valued using the acquisition date closing price of $2.86. The fair value of common stock held in escrow consisted of 0.5 million shares of Class A common stock valued using the acquisition date closing price of $2.86. These shares are being held in escrow pending resolution of net working capital adjustments and certain indemnification matters, as described in the Merger Agreement.
CY2023Q1	prpl	Fair Value Of Effective Settlement FairValueOfEffectiveSettlement	1400000	usd
CY2023Q1	prpl	Fair Value Acquisition Amount FairValueAcquisitionAmount	300000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1400000	usd
CY2023Q1	prpl	Payable Amount PayableAmount	300000	usd
CY2022	prpl	Payable Amount PayableAmount	300000	usd
CY2023Q1	prpl	Measurement Period MeasurementPeriod	P1Y
CY2023Q1	us-gaap	Investments And Cash InvestmentsAndCash	1700000	usd
CY2023Q1	prpl	Operating Expenses Description OperatingExpensesDescription	purpose of the escrow cash amount was to cover Intellibed’s estimated state income tax liabilities, sales tax liabilities and related filing expenses that existed prior to the acquisition date.
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1700000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1300000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1300000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1900000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1900000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	31771000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	31803000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4344000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2261000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	52735000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	40476000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1169000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1343000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	87681000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	73197000	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	71009000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	66533000	usd
CY2023Q1	prpl	Equipment In Progress EquipmentInProgress	16257000	usd
CY2022Q4	prpl	Equipment In Progress EquipmentInProgress	19099000	usd
CY2023Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	56561000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	56114000	usd
CY2023Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26238000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26290000	usd
CY2023Q1	prpl	Office Equipment OfficeEquipment	3777000	usd
CY2022Q4	prpl	Office Equipment OfficeEquipment	4393000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	173842000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	172429000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39748000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	134094000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	136673000	usd
CY2023Q1	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	400000	usd
CY2022Q4	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	200000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	4800000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	3600000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P16Y
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1000000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1000000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	4885000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3148000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	973000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	714000	usd
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	5858000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	3873000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P5Y
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14675000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	20464000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	20040000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	18823000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	19090000	usd
CY2023Q1	prpl	Thereafter Thereafter	70113000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	163205000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	33770000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129435000	usd
CY2023Q1	prpl	Leases Undiscounted Amount leasesUndiscountedAmount	15700000	usd
CY2023Q1	prpl	Improvement Allowances ImprovementAllowances	1000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	50000000	usd
CY2023Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	600000	usd
CY2022Q1	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	1100000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	17876000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	3406000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1435000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2209000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12751000	usd
CY2022Q4	prpl	Related Party Loan RelatedPartyLoan	24656000	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	999000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	23657000	usd
CY2022	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	15000000	usd
CY2023Q1	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	24700000	usd
CY2023Q4	us-gaap	Ratio Of Indebtedness To Net Capital1 RatioOfIndebtednessToNetCapital1	2	pure
CY2023Q4	us-gaap	Federal Home Loan Bank Leverage Ratio Actual1 FederalHomeLoanBankLeverageRatioActual1	0.02	pure
CY2023Q1	us-gaap	Legal Fees LegalFees	5000000	usd
CY2022	us-gaap	Legal Fees LegalFees	2000000	usd
CY2023Q1	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	the amendment (i) reduced the amount available under the revolving line of credit to $50.0 million, (ii) provided that the maturity date of the 2020 Credit Agreement will spring forward to June 30, 2024 if consolidated EBITDA is not greater than $15.0 million for 2023, (iii) reduced limits on maximum growth capital expenditures to $32.0 million for 2023 and $35.0 million for 2024 and 2025, and (iv) revised the current minimum liquidity covenant of $25.0 million to provide that it will increase to $30.0 million for each three-month period following the applicable fiscal quarter if the leverage ratio is greater than 3.00x for any fiscal quarter ending on or after the third quarter of 2023.
CY2023Q1	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	2900000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1200000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1900000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1900000	shares
CY2023Q1	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	400000	usd
CY2023Q1	prpl	Schedule Of Fair Value Of Incremental Warrants ScheduleOfFairValueOfIncrementalWarrants	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt">Trading price of common stock on measurement date</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5.85</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Exercise price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.75</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Risk free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.63</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Warrant life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.8</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Expected volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72.84</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">—</div></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	prpl	Warrant Description WarrantDescription	During the three months ended March 31, 2022, the Company recognized a gain of $3.9 million in its condensed consolidated statements of operations related to a decrease in the fair value of the sponsor warrants outstanding at the end of the period.
CY2023Q1	prpl	Other Long Term Liabilities OtherLongTermLiabilities	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13. Other Long-Term Liabilities</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other long-term liabilities consist of the following (in thousands):</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">March 31,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; text-transform: uppercase; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-transform: uppercase; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-transform: uppercase"> </td><td style="font-weight: bold; text-transform: uppercase; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-transform: uppercase; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-transform: uppercase"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Warranty accrual</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,997</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">20,744</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -9pt; padding-left: 9pt">Asset retirement obligations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,131</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,098</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">14</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">19</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -9pt; padding-left: 9pt">Total</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,142</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,861</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Less – current portion of warranty accrual</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,390</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,985</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Other long-term liabilities, net of current portion</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,752</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">17,876</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	19997000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	20744000	usd
CY2023Q1	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2131000	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	2098000	usd
CY2023Q1	prpl	Other Longterm Liabilities OtherLongtermLiabilities	14000	usd
CY2022Q4	prpl	Other Longterm Liabilities OtherLongtermLiabilities	19000	usd
CY2023Q1	us-gaap	Other Long Term Debt OtherLongTermDebt	22142000	usd
CY2022Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	22861000	usd
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	4390000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	4985000	usd
CY2023Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	17752000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	20744000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	15013000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	696000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2163000	usd
CY2023Q1	us-gaap	Malpractice Loss Contingency Claims Incurred In Period MalpracticeLossContingencyClaimsIncurredInPeriod	1443000	usd
CY2022Q1	us-gaap	Malpractice Loss Contingency Claims Incurred In Period MalpracticeLossContingencyClaimsIncurredInPeriod	808000	usd
CY2023Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	19997000	usd
CY2022Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	16368000	usd
CY2023Q1	prpl	Required Member Distributions Percentage RequiredMemberDistributionsPercentage	0.45	pure
CY2023Q1	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	100000	usd
CY2018Q1	prpl	Aggregate Amount AggregateAmount	4000000	usd
CY2018Q1	prpl	Subscription Agreement And Preemptive Rights Description SubscriptionAgreementAndPreemptiveRightsDescription	(i) an aggregate of 1.3 million additional shares of Class A common stock to CCP and Blackwell and (ii) an aggregate of 3.3 million warrants to purchase 1.6 million shares of Class A common stock to CCP, Blackwell, and Coliseum Co-Invest Debt Fund, L.P. (“CDF”).
CY2020Q3	prpl	Trade Seeking Amount TradeSeekingAmount	7000000	usd
CY2023Q1	prpl	Paid Under Agreement PaidUnderAgreement	900000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	100000	usd
CY2023Q1	prpl	Seeks Over Damages SeeksOverDamages	100000	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	4000000	usd
CY2022Q3	prpl	Against Numerous Entities Description AgainstNumerousEntitiesDescription	(a) violated Lanham Act § 43(a), 15 U.S.C. § 1125(a) by committing acts of trade dress infringement; (b) infringed U.S. Trademark Registration No. 5,661,556; (c) infringed U.S. Trademark Registration No. 6,551,053; (d) violated Lanham Act § 43(a), 15 U.S.C. § 1125(a) by committing acts of trademark infringement; I infringed U.S. Patent No. D909,092; (f) infringed U.S. Patent No. 10,772,445; (g) infringed U.S. Patent No. 10,863,837; (h) violated Utah Unfair Competition Act, Utah Code § 13-5a-101 et seq.; and/or (i) committed common law unfair competition.
CY2022Q4	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	500000	usd
CY2023Q1	prpl	Number Of Shares NumberOfShares	100	shares
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	10,000
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1000000	usd
CY2023Q1	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1000000	shares
CY2023Q1	prpl	Warrants Issued WarrantsIssued	1000000	shares
CY2023Q1	prpl	Warrants Description WarrantsDescription	the Company’s Class A common stock at a price of $5.75 per half share ($11.50 per full share), subject to adjustment as specified in the warrant agreement.
CY2023Q1	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	100000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit Intraperiod Tax Allocation IncomeTaxExpenseBenefitIntraperiodTaxAllocation	1800000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.0031	pure
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.1173	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.80	pure
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares	400000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	168500000	usd
CY2022	prpl	Termination Fee TerminationFee	110600000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-23300000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13502000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	-107000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest	-129000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-23407000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-13631000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98404	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67058	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	448	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	448	shares
CY2023Q1	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	98852	shares
CY2022Q1	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	67506	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.2
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.2
CY2023Q1	prpl	Shares Of Common Stock Issuable Upon Conversion Of Warrant SharesOfCommonStockIssuableUponConversionOfWarrant	2400000	shares
CY2022Q1	prpl	Shares Of Common Stock Issuable Upon Conversion Of Warrant SharesOfCommonStockIssuableUponConversionOfWarrant	3600000	shares
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	800000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	819000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.68
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	44000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.02
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	775000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.72
CY2023Q1	prpl	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageContractualTerm	P1Y9M18D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	307000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.84
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	202000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.21
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	22000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.7
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	83000	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.41
CY2023Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	300000	usd
CY2022Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	200000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1235000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.47
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	284000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.38
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	132000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	5.87
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	819000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.09
CY2023Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	800000	usd
CY2022Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	400000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2023Q1	prpl	Total Noncash Stock Compensation And Associated Line Item On Statement Of Operations TotalNoncashStockCompensationAndAssociatedLineItemOnStatementOfOperations	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended<br/> March 31,</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketing and sales</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,120</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">323</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total non-cash stock-based compensation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,192</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">542</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2023Q1	prpl	Total Noncash Stockbased Compensation TotalNoncashStockbasedCompensation	1192000	usd
CY2022Q1	prpl	Total Noncash Stockbased Compensation TotalNoncashStockbasedCompensation	542000	usd
CY2023Q1	us-gaap	General Discussion Of Pension And Other Postretirement Benefits GeneralDiscussionOfPensionAndOtherPostretirementBenefits	The plan provides for Company matching of employee contributions up to 5% of eligible earnings.
CY2023Q1	prpl	Defined Contribution Plan Cost Recognized1 DefinedContributionPlanCostRecognized1	900000	usd
CY2022Q1	prpl	Defined Contribution Plan Cost Recognized1 DefinedContributionPlanCostRecognized1	1100000	usd
CY2023Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3000000	usd
CY2023Q1	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	4000000	usd
CY2023Q1	prpl	Ownership Of Voting Securities Percentage OwnershipOfVotingSecuritiesPercentage	0.444	pure
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Purple Innovation, Inc.
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2023Q1	prpl	Debt Debt		usd
CY2022Q4	prpl	Common Stock Value2 CommonStockValue2		usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023Q1	prpl	Fair Value Warrant Liabilities FairValueWarrantLiabilities		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023Q1	prpl	Related Party Loan RelatedPartyLoan		usd
CY2023Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense		usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q1	prpl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term In Years Granted SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermInYearsGranted
CY2023Q1	prpl	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period To Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodToIntrinsicValue		usd
CY2023Q1	prpl	Stock Issued During Period Share Stock Options Exercised StockIssuedDuringPeriodShareStockOptionsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	prpl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term In Years Exercised SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermInYearsExercised
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q1	prpl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term In Years Forfeitedexpired SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTermInYearsForfeitedexpired
CY2023Q1	prpl	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodTotalIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	prpl	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrants		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001643953

Files In Submission

Name	View Source	Status
prpl-20230331_cal.xml	Edgar Link	unprocessable
0001213900-23-038113-index-headers.html	Edgar Link	pending
0001213900-23-038113-index.html	Edgar Link	pending
0001213900-23-038113.txt	Edgar Link	pending
0001213900-23-038113-xbrl.zip	Edgar Link	pending
f10q0323ex10-13_purple.htm	Edgar Link	pending
f10q0323ex31-1_purple.htm	Edgar Link	pending
f10q0323ex31-2_purple.htm	Edgar Link	pending
f10q0323ex32-1_purple.htm	Edgar Link	pending
f10q0323ex32-2_purple.htm	Edgar Link	pending
f10q0323_purple.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prpl-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
prpl-20230331_def.xml	Edgar Link	unprocessable
prpl-20230331_pre.xml	Edgar Link	unprocessable
prpl-20230331_lab.xml	Edgar Link	unprocessable
f10q0323_purple_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRPL
Purple Innovation, Inc. Stock $prpl

2023 Q1 Form 10-Q Financial Statement

#000121390023038113 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPL Purple Innovation, Inc. Stock $prpl

2023 Q1 Form 10-Q Financial Statement

#000121390023038113 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRPL
Purple Innovation, Inc. Stock $prpl